amikacin has been researched along with Infection Reactivation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coria-Jiménez, VR; Cuevas-Schacht, F; Gerónimo-Gallegos, A; Gutiérrez-Santana, JC; López-López, M; Martínez-Corona, MB; Toscano-Garibay, JD | 1 |
1 other study(ies) available for amikacin and Infection Reactivation
| Article | Year |
|---|---|
High Rates of Extensively Drug-Resistant Pseudomonas aeruginosa in Children with Cystic Fibrosis.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ceftazidime; Child; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Random Amplified Polymorphic DNA Technique; Reinfection | 2022 |